Impute is a digital medicine that offers artificial intelligence, IoT, and green tech solutions for neurological disorders.
Impute has raised $1.3M in total funding. The most recent round was Series A. The last funding was announced in January 2022.
Impute's investors include i-nest capital.
Impute is headquartered in Marunouchi, Japan.
Impute is a digital medicine that offers artificial intelligence, IoT, and green tech solutions for neurological disorders.
Impute is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Impute — Funding & Investors." VCBacked, January 13, 2022, https://www.vcbacked.co/company/impute. Accessed August 14, 2026.
VCBacked. (2022). Impute — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/impute
{{cite web |title=Impute — Funding & Investors |url=https://www.vcbacked.co/company/impute |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated